Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas. According to GlobalData, Phase II drugs for Unspecified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback